Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhishan Deng

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Respiratory Medicine|June 3, 2018
Clinical impact of the lower limit of normal of FEV<sub>1</sub>/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional dataSha Liu, Yumin Zhou, Shiliang Liu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 17, 2025
Risk of All-Cause Mortality in US Adults With Preserved Ratio Impaired Spirometry: An Observational StudyShan Xiao, Jie Ou, Wangli Qiu, et al.
Pulmonology|December 14, 2023
Association of mild chronic obstructive pulmonary disease with all-cause mortality: A systematic review and meta-analysisWeifeng Zou, Jie Ou, Fan Wu, et al.
Environmental Pollution (Barking, Essex : 1987)|March 26, 2024
Association between long-term ozone exposure and readmission for chronic obstructive pulmonary disease exacerbationHuajing Yang, Zihui Wang, Yumin Zhou, et al.
NPJ Primary Care Respiratory Medicine|April 6, 2026
Identifying patients with mild-to-moderate COPD who require intensified initial treatment to control annualized clinically important deteriorationZihui Wang, Yumin Zhou, Wei-Jie Guan, et al.
Pulmonology|January 30, 2025
Increased plasma interleukin-1β is associated with accelerated lung function decline in non-smokersXinru Ran, Haiqing Li, Zihui Wang, et al.
Trials|September 12, 2020
High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I-II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in ChinaHeshen Tian, Yumin Zhou, Longhui Tang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 12, 2024
The Nonlinear Relationship Between High-Density Lipoprotein and Changes in Pulmonary Structure Function and Pulmonary Function in COPD Patients in ChinaXiang Wen, Xiaohui Wu, Zhishan Deng, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2025
Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007-2012Weifeng Zou, Jie Ou, Fan Wu, et al.
Respiratory Research|October 26, 2021
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary diseaseNaijian Li, Zhouli Dai, Zhang Wang, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Respiratory Medicine|June 3, 2018
Clinical impact of the lower limit of normal of FEV<sub>1</sub>/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional dataSha Liu, Yumin Zhou, Shiliang Liu, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 17, 2025
Risk of All-Cause Mortality in US Adults With Preserved Ratio Impaired Spirometry: An Observational StudyShan Xiao, Jie Ou, Wangli Qiu, et al.
Pulmonology|December 14, 2023
Association of mild chronic obstructive pulmonary disease with all-cause mortality: A systematic review and meta-analysisWeifeng Zou, Jie Ou, Fan Wu, et al.
Environmental Pollution (Barking, Essex : 1987)|March 26, 2024
Association between long-term ozone exposure and readmission for chronic obstructive pulmonary disease exacerbationHuajing Yang, Zihui Wang, Yumin Zhou, et al.
NPJ Primary Care Respiratory Medicine|April 6, 2026
Identifying patients with mild-to-moderate COPD who require intensified initial treatment to control annualized clinically important deteriorationZihui Wang, Yumin Zhou, Wei-Jie Guan, et al.
Pulmonology|January 30, 2025
Increased plasma interleukin-1β is associated with accelerated lung function decline in non-smokersXinru Ran, Haiqing Li, Zihui Wang, et al.
Trials|September 12, 2020
High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD I-II): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in ChinaHeshen Tian, Yumin Zhou, Longhui Tang, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 12, 2024
The Nonlinear Relationship Between High-Density Lipoprotein and Changes in Pulmonary Structure Function and Pulmonary Function in COPD Patients in ChinaXiang Wen, Xiaohui Wu, Zhishan Deng, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 4, 2025
Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007-2012Weifeng Zou, Jie Ou, Fan Wu, et al.
Respiratory Research|October 26, 2021
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary diseaseNaijian Li, Zhouli Dai, Zhang Wang, et al.
Pageof 8